Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Tscan Therapeutics (TCRX)

Annual Return

Over the past 3 years, TCRX has had an average annual return of -29.82%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Jul 16, 2021, TCRX has had an average annual return of -38.56%, underperforming the benchmark SPY, which returned +13.62% annual.

202620252024202320222021
-2.73%-67.12%-47.86%+276.15%-65.56%-57.14%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+2%+4.02%-4.75%+14.86%-6.88%-10.01%-2.73%
2025-15.44%-18.30%-34.30%+16.36%-10.92%+1.40%+19.99%+3.44%+1.11%+6.64%-42.80%-9.93%-67.12%
2024-12.34%+32.09%+17.62%-2.78%+10.76%-31.59%+22.06%-21.15%-11.54%-8.83%+5.06%-36.28%-47.86%
2023+17.41%+62.15%-28.83%+8.10%+1.30%+8.72%-10.42%+6.28%+7.54%+50.41%+69.59%-10.73%+276.15%
2022+7.33%-13.04%-33.33%-23.21%+48.83%-1.74%+39.60%-37.36%+10.92%-11.50%-19.99%-28.25%-65.56%
2021-7.62%-8.35%-6.19%+5.04%-12.56%-41.25%-57.14%

Drawdown analysis of Tscan Therapeutics (TCRX)

The maximum drawdown for the TCRX was -93.36%, occurring on Dec 19, 2025. This drawdown has not yet recovered.

The current TCRX drawdown is -92.79%.

Since Jul 16, 2021 TCRX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-93.36%Aug 18, 20211090Dec 19, 2025OngoingOngoingOngoing
-9.52%Jul 20, 20215Jul 27, 20215Aug 3, 202110
-9.40%Aug 4, 20215Aug 11, 20213Aug 16, 20218
-4.67%Jul 16, 20211Jul 19, 20211Jul 20, 20212